News Medical on MSN
New combination treatment overcomes resistance in ER positive breast cancer
In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School ...
Marsden Funding To Drive Discovery And Innovation In Cancer, Allergy And Infectious Disease Research
Dr David O’Sullivan has been awarded a Marsden Fund Standard Grant to explore ways to optimise T-cells to cope with increased ...
Investigators from Mass General Brigham have developed a way to promote antitumor immunity by hijacking cellular machinery within cancer cells.
The body has to clear away dead cells and other unnecessary or unneeded stuff, and one mechanism that is crucial to the ...
TuHURA Biosciences, Inc. (NASDAQ: HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to ...
Novel Model Integrating TME Composition with TLS Gene Signatures Predicts Meaningful Survival Differences in Checkpoint Inhibitor-Treated Patients Cellworks Group Inc., a leader in Personalized ...
A specific subtype of tumor-associated macrophage is more abundant in endocrine therapy-resistant tumors, and targeting these ...
Triple therapy approach that hits cancer from multiple angles at once could be a game-changer against breast cancers that no longer respond to hormone treatment.
Spatial biology is reshaping how researchers study cancer by revealing the architecture and complexity of tumors in extraordinary detail. Through techniques that combine protein- and gene-level ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results